Avenue Therapeutics Capital Surpluse Over Time
| ATXI Stock | USD 2.08 0.07 3.48% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avenue Therapeutics Performance and Avenue Therapeutics Correlation. Avenue |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share 24.78 | Return On Assets (2.01) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capital Surpluse Analysis
Compare Avenue Therapeutics and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Capital Surpluse Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPR | 45.6 M | 45.6 M | 46.5 M | 15.6 M | 16.1 M | 34.1 M | 50 M | 62.7 M | 71.3 M | 81.2 M | 116.2 M | 139.4 M | 148.7 M | 171 M | 179.6 M |
| SLNO | 60.6 M | 60.6 M | 60.6 M | 60.6 M | 60.6 M | 89.5 M | 101.7 M | 140.5 M | 157.4 M | 172.7 M | 227.9 M | 227.9 M | 227.9 M | 262.1 M | 149.3 M |
| BPTH | 12.4 M | 12.4 M | 14.1 M | 20.1 M | 35.1 M | 35.1 M | 40.3 M | 47.2 M | 49 M | 77.4 M | 82.3 M | 82.3 M | 82.3 M | 94.6 M | 99.4 M |
| MBRX | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 31.6 M | 40.6 M | 55.1 M | 74.7 M | 74.7 M | 74.7 M | 85.9 M | 48.7 M |
| CRNX | 900 K | 900 K | 900 K | 900 K | 900 K | 900 K | 900 K | 1.2 M | 203.5 M | 203.5 M | 203.5 M | 203.5 M | 203.5 M | 234 M | 245.8 M |
| ASMB | 102 M | 102 M | 110.1 M | 135.8 M | 194.1 M | 283.5 M | 288.7 M | 364.5 M | 552.8 M | 712.8 M | 742.4 M | 807.9 M | 807.9 M | 929.1 M | 975.6 M |
| TIL | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 757 M | 681.3 M | 605.6 M |
| CTMX | 243.7 M | 243.7 M | 243.7 M | 243.7 M | 243.7 M | 243.7 M | 254.9 M | 289.5 M | 446 M | 468.3 M | 500 M | 623.3 M | 623.3 M | 716.8 M | 474.2 M |
Avenue Therapeutics and related stocks such as Capricor Therapeutics, Soleno Therapeutics, and Bio Path Holdings Capital Surpluse description
My Equities
My Current Equities and Potential Positions
| Avenue Therapeutics | ATXI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 2.08
Check out Avenue Therapeutics Performance and Avenue Therapeutics Correlation. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Avenue Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.